Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. reports developments tied to healthcare intelligence, data and analytics technology, and professional services for healthcare organizations. Company updates commonly cover operating results, revenue and Adjusted EBITDA guidance, and the use of AI-driven technology and domain expertise to support health systems across cost, clinical, and consumer performance.
Recurring news also includes leadership and board governance changes, shareholder-related board appointments, investor conference participation, and updates on strategic focus areas for its healthcare data platform, analytics applications, implementation, advisory, outsourcing, and improvement services.
Health Catalyst (Nasdaq: HCAT) has announced an expanded partnership with Contexture, a nonprofit regional health information exchange organization. The partnership now includes technology and services support for Quality Health Network (QHN), a Contexture affiliate in western Colorado. This expansion follows Contexture and QHN's affiliation in May 2024 to unify services in Colorado and the western slope.
The collaboration will leverage Ninja Universe by Health Catalyst™, a cloud-native platform designed for Health Information Exchanges (HIEs). This platform aggregates, normalizes, and optimizes multi-source healthcare data in real-time, supporting Contexture and QHN's efforts to improve data sharing and patient care in Arizona and Colorado.
Health Catalyst (Nasdaq: HCAT) has expanded its long-term partnership with South Dakota Health Link, enhancing technology and services. This agreement includes migrating to the Ninja Universe, a cloud-native platform for Health Information Exchanges (HIEs), which aggregates and optimizes healthcare data in real-time. South Dakota Health Link serves communities in South Dakota, Wyoming, Minnesota, Iowa, North Dakota, and Nebraska. The collaboration aims to improve healthcare quality, safety, and efficiency by providing healthcare providers, pharmacists, and social workers with real-time data and insights.
Health Catalyst (Nasdaq: HCAT) reported strong Q2 2024 financial results, with total revenue of $75.9 million and Adjusted EBITDA of $7.5 million, both exceeding mid-point guidance. The company saw significant growth in net new Platform Subscription Clients, signing more in H1 2024 than in all of 2023. Key financial metrics include:
- Total revenue: $75.9 million (4% YoY increase)
- Gross profit: $28.8 million (8% YoY increase)
- Gross margin: 38% (up from 36% in Q2 2023)
- Net loss: $13.5 million (59% YoY improvement)
- Adjusted Gross Profit: $37.8 million (4% YoY increase)
- Adjusted EBITDA: $7.5 million (114% YoY increase)
CEO Dan Burton expressed satisfaction with the company's bookings performance and projected a record year for new Platform Subscription Clients.
Health Catalyst (Nasdaq: HCAT), a leading provider of data and analytics technology for healthcare organizations, has announced its plans to release second quarter 2024 operating results on Wednesday, August 7, 2024, after market close. The company will host a conference call at 5 p.m. E.T. on the same day to review the results.
Participants can join the call by dialing 800-267-6316 (U.S.) or 203-518-9783 (international) with the conference ID "HCATQ224". A live audio webcast will be available at https://ir.healthcatalyst.com/, with a replay accessible shortly after the call for approximately 90 days.
Health Catalyst (Nasdaq: HCAT) has secured a $225 million credit facility with Silver Point Finance. The facility includes an initial $125 million term loan and a $100 million delayed draw option. The company will use the funds to refinance existing convertible notes due in 2025 and support its growth strategy.
CEO Dan Burton emphasized the importance of this non-dilutive capital for pursuing organic and inorganic growth opportunities. CFO Jason Alger highlighted the flexibility of the financing structure, allowing Health Catalyst to address near-term debt maturity while focusing on creating shareholder value and maintaining a strong balance sheet.
Health Catalyst (Nasdaq: HCAT) has completed its acquisition of Carevive Systems, a health technology company specializing in oncology. Carevive's platform is used for treatment care planning, clinical trial screening, care coordination, remote patient monitoring, and post-treatment care. This acquisition will enhance Health Catalyst's capabilities in oncology care and patient-reported outcomes. Both companies aim to leverage data and analytics to improve patient care and outcomes. The integration promises to deliver innovative solutions to cancer centers and provide researchers with valuable real-world data.
Health Catalyst (Nasdaq: HCAT), a top provider of data and analytics technology in healthcare, announced its participation in key investor conferences. CFO Jason Alger and VP of Investor Relations Jack Knight will represent the company.
They will attend The Stifel Cross Sector Insight Conference in Boston, featuring a fireside chat on June 4, 2024, at 9:45am ET. Additionally, they will present at The Goldman Sachs 45th Annual Global Healthcare Conference in Miami, scheduled for June 12, 2024, at 8:40am ET.
Health Catalyst (Nasdaq: HCAT) has launched Health Catalyst Ignite®, a next-generation data and analytics ecosystem designed for the healthcare sector. The platform integrates advanced technologies, healthcare-specific data models, self-service tools, and industry expertise to address the challenges of data management in healthcare. Ignite offers seamless integration, scalability, and flexibility, reducing costs and improving decision-making. It enables data sharing, centralizes data governance, and democratizes analytics to provide faster insights and enhanced control. The platform supports a range of healthcare use cases, from clinical improvement to operational efficiency, leveraging AI and machine learning for predictive insights.
Health Catalyst, Inc. reported strong financial results for the first quarter of 2024, with total revenue of $74.7 million and Adjusted EBITDA of $3.4 million, beating guidance mid-points. The company remains focused on long-term profitability goals and reaffirmed its full-year guidance for 2024. Key metrics show growth in gross profit and margins, with a 1% increase in total revenue year over year. However, there was a 19% decrease in Adjusted EBITDA compared to the same period last year.
Summary not available.